HSA — authorised 17 April 1998
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
HSA authorised Zemplar on 17 April 1998
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 17 April 1998.
ABBVIE holds the Singaporean marketing authorisation.